-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JYlpWBN2BLaOiEJguguqQuz66VwhJh/45cu1Xs0UfX1H8mcDGQWienU5u13Ila0F W1rVBGH38BB14jry09WX2Q== 0001176256-08-000465.txt : 20080410 0001176256-08-000465.hdr.sgml : 20080410 20080410151205 ACCESSION NUMBER: 0001176256-08-000465 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080410 DATE AS OF CHANGE: 20080410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIOTECH PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001096481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1618 STATION STREET CITY: VANCOUVER STATE: A1 ZIP: V6A 1B6 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neske Tammy CENTRAL INDEX KEY: 0001432056 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30334 FILM NUMBER: 08749875 BUSINESS ADDRESS: BUSINESS PHONE: 604-221-7676 MAIL ADDRESS: STREET 1: 1618 STATION STREET CITY: VANCOUVER STATE: A1 ZIP: V6A 1B6 3 1 primary_doc.xml PRIMARY DOCUMENT X0202 3 2008-03-31 0 0001096481 ANGIOTECH PHARMACEUTICALS INC ANPI 0001432056 Neske Tammy 16255 28TH AVENUE SURREY A1 V3S 0E4 BRITISH COLUMBIA, CANADA 0 1 0 0 Sr. VP Human Resources Awards 17.41 2006-01-01 2010-12-01 Common Stock 8400 D Awards 17.5 2006-04-01 2011-03-26 Common Stock 16600 D Awards 8.9 2007-03-01 2012-02-04 Common Stock 50000 D The option is currently exercisable as to 4725 shares. The option became exercisable on 1/1/2006 and will continue to vest with respect to the remaining 3675 shares in equal installments on a monthly basis until 12/1/2009. The option is currently exercisable as to 8300 shares. The option became exercisable on 4/1/2006 and will continue to vest with respect to the remaining 8300 shares in equal installments on a monthly basis until 3/1/2010. The option is currently exercisable as to 13542 shares. The option became exercisable on 3/1/2007 and will continue to vest with respect to the remaining 36458 shares in equal installments on a monthly basis until 2/1/2011. All Conversion or Exercise Prices are in Canadian funds. /s/ Tammy Neske 2008-04-10 -----END PRIVACY-ENHANCED MESSAGE-----